Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.31 USD
Change Today +0.01 / 0.77%
Volume 4.1K
CASM On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 10:11 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

cas medical systems inc (CASM) Snapshot

Open
$1.28
Previous Close
$1.30
Day High
$1.31
Day Low
$1.28
52 Week High
05/5/14 - $2.33
52 Week Low
02/11/15 - $1.16
Market Cap
35.0M
Average Volume 10 Days
110.5K
EPS TTM
$-0.43
Shares Outstanding
26.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CAS MEDICAL SYSTEMS INC (CASM)

Related News

No related news articles were found.

cas medical systems inc (CASM) Related Businessweek News

No Related Businessweek News Found

cas medical systems inc (CASM) Details

CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets medical devices for non-invasive patient monitoring in the United States and internationally. The company provides FORE-SIGHT series of absolute tissue oximeters and sensors, including the FORE-SIGHT ELITE oximeter; and traditional monitoring products, such as blood pressure measurement technologies, bedside monitoring products, and neonatal intensive care supplies. It also offers vital signs monitors and accessories incorporating various combinations of measurement parameters for human and veterinary use, such as MAXNIBP and MAXIQ non-invasive blood pressure, pulse oximetry, electro-cardiography, temperature, and capnography; and supplies and services, including neonatal intensive care vital signs supplies, such as electrodes and skin temperature probes, as well as various repair services. The company markets its products through its own sales force, manufacturers’ representatives, and original equipment manufacturers, as well as through hospital, surgery center and outpatient facility, homecare, veterinary, and emergency medical distribution channels. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.

96 Employees
Last Reported Date: 03/18/15
Founded in 1984

cas medical systems inc (CASM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $311.9K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $216.3K
Vice President of Research & Development
Total Annual Compensation: $189.4K
Compensation as of Fiscal Year 2013.

cas medical systems inc (CASM) Key Developments

CAS Medical Systems, Inc. Receives FDA Approval for FORE-SIGHT® ELITE in Pediatric and Neonatal Patients

CAS Medical Systems Inc. announced receipt of an expanded label for its FORE-SIGHT® ELITE oximeters from the U.S. Food and Drug Administration (FDA) to include its new medium and small sensors for use with pediatric and neonatal patients. With the launch of the FORE-SIGHT ELITE for pediatric and neonatal patients, the company will have the ability to address additional sales channels and call points within a hospital with the exact same monitor. The company is on track to introduce the FORE-SIGHT ELITE in this market segment in the late third or early fourth quarter of this year.

CAS Medical Systems Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Revenue Guidance for the Year 2015

CAS Medical Systems Inc. reported unaudited earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net sales of USD 5,827,962 compared with USD 5,944,370 for the same period last year. Operating loss was USD 1,571,187 compared with USD 3,094,383 for the same period last year. Net loss applicable to common stockholders was USD 2,122,104 or USD 0.11 basic and diluted share compared with USD 3,489,900 or USD 0.19 basic and diluted shares for the same period last year. For the full year, the company reported net sales of USD 22,913,249 compared with USD 21,915,794 for the same period last year. Operating loss was USD 6,832,656 compared with USD 10,453,446 for the same period last year. Net loss applicable to common stockholders was USD 8,892,008 or USD 0.46 basic and diluted share compared with USD 11,566,161 or USD 0.73 per basic and diluted share for the same period last year. For the year 2015, the company looks forward to achieving its goal of strong FORE-SIGHT revenue growth in 2015 of approximately 30%.

CAS Medical Systems, Inc. Appoints Paul A. Molloy to the Board

Effective January 5, 2015, the Board of Directors of CAS Medical Systems Inc. appointed Paul A. Molloy to fill the vacancy on the Board resulting from the departure of Lawrence S. Burstein. On February 25, 2015, the Board of Directors of the company appointed Mr. Molloy to serve on the Audit Committee of the Board of Directors.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CASM:US $1.31 USD +0.01

CASM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
General Electric Co $26.90 USD +0.096
Koninklijke Philips NV €27.92 EUR +0.56
Masimo Corp $35.14 USD +0.31
Mindray Medical International Ltd $31.20 USD +0.25
Omron Corp ¥5,520 JPY +100.00
View Industry Companies
 

Industry Analysis

CASM

Industry Average

Valuation CASM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAS MEDICAL SYSTEMS INC, please visit www.casmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.